ICU Acquired Weakness Clinical Trial
Official title:
Effect of Transcutaneous Electrical Diaphragmatic Stimulation on Respiratory Muscle Strength, Diaphragm Thickness and Mechanical Ventilation Time in Critically Ill Elderly Patients
Abstract..................................................................................... .....................04 Introduction................................................................................. ...................10 Methods...................................................................................... ...................14 Financial Support...................................................................................... .....22 References................................................................................... ..................24
1. INTRODUCTION Patients undergoing invasive mechanical ventilation (IMV) have an intense
predisposition to the development of muscle weakness in the first hours after the
orotracheal intubation process, since they are exposed, among other factors, to sedative
drugs, immobilization and properly controlled ventilation (DEMOULE et al., 2016). It is
observed that approximately 25% to 50% of patients submitted to ventilatory support have
muscle weakness and, of this proportion, 85% to 95% persist with neuromuscular
impairment for a period of two to five years.
In this context, the elderly deserve attention because the demographic transition
process has the inversion of the age pyramid as one of its characteristics (WONG et al.,
2006). This leads to a higher incidence of admissions of these patients in intensive
care units compared to young people and adults, considering that they represent the
largest portion of the population.
Among the muscles affected by permanence in IMV in the general population and especially
in the elderly, the diaphragm can be highlighted, which evolves with a reduction in its
ability to generate tension due to the atrophy of its muscle fibers. This leads to an
alteration called diaphragmatic dysfunction (DD). The mechanisms involved with DD are
the reduction in the number of myofibrils (proteins that involve filaments of actin and
myosin responsible for the production of muscle contraction), oxidative stress (inducing
the activation of the forkhead box O1 protein, involved with the processes of
gluconeogenesis and glycogenolysis) and the abnormal activation of a pathway responsible
for the proteolysis of adenosine triphosphate, ubiquitin-proteasome.
Considering the progressive characteristic of DD, some consequences such as increased
IMV time, increased risk of respiratory complications and prolonged hospital stay can be
observed, if no specific intervention is performed . Therefore, it is necessary to adopt
measures that allow the early detection of diaphragmatic weakness, as well as the use of
conducts that prevent or treat this clinical condition.
As for the diagnosis of DD, it can be performed using instruments that measure
inspiratory muscle strength, such as the manovacuometer, in addition to imaging tests
that show the diaphragmatic thickness (FDI), such as pulmonary ultrasonography (PU) .
The variable referring to inspiratory muscle strength in manovacuometry is the maximum
inspiratory pressure (MIP), while the thickness of the diaphragm, verified through the
PU, is represented by the diaphragmatic thickening index (DTI), obtained through the
difference between the diaphragm thickness total lung capacity (DTTLC) and functional
residual capacity (DTFRC), divided by DTTLC. The FDI contributes to the initial
diagnosis of DD and is also relevant for monitoring the evolution of diaphragm function
during the period of hospitalization and ventilatory weaning. According to Goligher et
al. (2015), the decrease in FDI is associated with impaired function of the diaphragm
and is correlated with low values of MIP in critically ill patients.
After obtaining variables related to the function of the diaphragm, as previously
described, conducts aimed at preventing or treating DD are important in an attempt to
minimize possible damage to the critical patient. Within outpatient pulmonary
rehabilitation, positive effects have been demonstrated with the use of electrotherapy,
specifically through the technique of transcutaneous electrical diaphragmatic
stimulation (TEDS) in patients with chronic obstructive pulmonary disease (COPD). This
technique consists of placing electrodes on the skin, in places close to the motor
points of the diaphragm, transmitting an intermittent current and generating action
potentials capable of producing muscle contractions. However, in the literature, there
is no evidence on the effects of this therapy on the FDI of elderly critically ill
patients, or even to assess the impact of TEDS on the time of mechanical ventilation and
hospitalization of this population. In view of the practicality of this treatment, its
low cost and the scarcity of evidence on this topic, the objective of the present study
will be to assess the influence of TEDS on respiratory muscle strength, diaphragm
thickness and duration of mechanical ventilation in critically ill patients under care
intensive.
2. METHODS
2.1. Study Design and Recruitment
The present study will be a controlled randomized clinical trial. It will also be
registered in the Clinical Trials.
All research participants will be submitted to the assessment of respiratory muscle
strength (manovacuometry) and diaphragm thickness (PU), and only EG patients will be
exposed to an intervention through the use of TEDS.
2.2. Sample
The sample will consist of participants of both sexes, over the age of 60, who have
undergone IMV. The research participants will be divided into a control group (CG) and
an experimental group (EG) and will carry out the same evaluation steps during the
spontaneous breathing test after weaning from mechanical ventilation, with only the EG
undergoing TEDS. The details of the intervention will be exposed later.
2.3 Proposed Procedures / Methods
The evaluation of the research subjects will take place in the Adult Intensive Care
Units (I and II) of the Hospital e Maternidade Therezinha de Jesus - Juiz de Fora.
2.3.1. Distribution of Participants, Evaluation and Intervention
The research participants will be submitted to the evaluation of the FDI through the PU,
as well as of the respiratory muscle strength, through the manovacuometry, immediately
after the ventilatory weaning. It is worth noting that weaning and extubation will be
carried out following an institutional checklist (Appendix I) for greater patient
safety.
The EG, immediately after the 24-hour period on VMI, will be submitted to TEDS, twice a
day, with an interval of six hours between therapies to prevent respiratory muscle
fatigue. Initially, it will be performed with the patient in assisted-controlled
ventilation mode and well adapted to ventilation. The sensitivity parameter will be
adjusted to the value necessary so that the contractions produced by electrical
stimulation do not trigger the mechanical ventilator, preventing episodes of asynchrony.
After the suspension of drugs with a sedative effect (such as benzodiazepines and
endogenous opioids) and the ventilatory drive is resumed, TEDS will continue to be used
in EG patients until extubation, in spontaneous ventilation, following the same
protocol, however with the sensitivity readjusted to the standardized values to prevent
muscle fatigue. The procedures will be detailed below.
2.3.2. Pulmonary Ultrasound
Ultrasonography is a simple, safe and relatively low-cost procedure that, when using
exact equipment and standardized techniques applied by trained professionals, provides
relevant information on the respiratory system that has been demonstrated over the last
few years (DEMI et al., 2014).
The patient will position himself in the supine position and there will be the use of
the linear transducer to evaluate the superficial structures and the cardiac transducer
to evaluate the deep ones. There is a wide range of techniques to be employed, but the
eight-zone assessment is practical and quick to perform in emergency assessment and in
intensive care patients. The latter consists of the scanning of four areas by
hemithorax, namely: zones 1 and 2 indicate the upper anterior chest wall and the lower
anterior one respectively, and zones 3 and 4 indicate the upper lateral chest wall as
well as the lower lateral wall, respectively.
The equipment used to perform all pulmonary ultrasound exams will be the GE LogiqE
(Logiq-E GE 2014, Contagem, MG, Brazil), from the Ultrasonography Sector of the Hospital
and Maternidade Terezinha de Jesus, Juiz de Fora (MG).
2.3.3. Assessment of Respiratory Muscle Strength
According to the American Thoracic Society (2002), the appropriate protocol for
obtaining the measurements related to respiratory muscle strength (MIP) must respect the
following characteristics: a) environment with a temperature of approximately 21ºC; b)
previous calibration of the manovacuometer; c) patient in a sitting posture (head
elevated by 90 °); and d) execution of a maximum inspiration starting from the residual
volume (RV) to reach the total lung capacity (TLC). The procedure must be repeated two
more times, with an interval of two minutes between repetitions (prevention of muscle
fatigue) and the measures of MIP and maximum expiratory pressure (MEP) considered will
be the highest recorded. The equipment used will be brand M120, with a scale of 4 cmH2O,
with variation of +/- 120 cmH2O.
2.3.4. Transcutaneous Electrical Diaphragmatic Stimulation
The TEDS protocol will consist of the following parameters: a) frequency of 30 Hz; b)
pulse width of 0.4 ms; c) respiratory rate of 15 irpm; d) holding time of 1 s; e) rise
time of 1 s; f) 2 s descent time; and g) 2 s non-stimulus time. Phrenics equipment
(Dualpex 961, Quark®, SP, Brazil) will be used. The positioning of the electrodes will
be performed according to a study by Cancelliero et al. (2012), who proposed the
placement of two electrodes in the right and left paraxiphoid regions, and two others in
the direction of the axillary midline, over the seventh intercostal space, also on the
right and left sides. The duration of the procedure will be 30 minutes, twice a day,
with a six-hour interval between applications, until the patient undergoes the
extubation process. As long as it does not have a level of consciousness, is not in
spontaneous ventilatory mode and without the use of drugs with a sedative effect, the
sensitivity of the ventilator will be adjusted in a way that does not trigger the
equipment, to avoid episodes of asynchrony. Immediately after recovering the level of
consciousness, resuming the ventilatory drive and suspending sedative drugs, the patient
during TEDS will be stimulated to inhale after the perception of the arrival of the
electric current, in spontaneous mode, and with the sensitivity adjusted to the baseline
values.
2.3.4. Scratchs
There are chances of hemodynamic decompensation and respiratory distress during the use
of TEDS in EG patients, including changes in heart rate, blood pressure, as well as
respiratory rate and synchronization with the mechanical ventilator. If the events
described occur, the TEDS procedure will be stopped immediately. Ventilatory adjustments
will be made by the researcher according to the demands presented and the doctor on duty
will be informed to adopt conducts aimed at the patients' hemodynamic recovery,
regarding medication adjustments. There will be supervision by the responsible
researcher and the rest of the multidisciplinary team.
2.3.5. Benefits
Benefits may be generated for the study participants, including the reduction in the
time of mechanical ventilation, hospitalization, in addition to the probable rapid
reintegration of patients into activities of daily living after discharge, since
diaphragmatic muscle weakness contributes substantially to the delay in the process of
recovering functionality.
3. FINANCIAL SUPPORT
The equipment used in the research is available at the Therezinha de Jesus Hospital and
Maternity Hospital in the city of Juiz de Fora, state of Minas Gerais.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04430283 -
Evaluation of FDY-5301 in Major Trauma Patients in ICU
|
Phase 2 | |
Completed |
NCT05527678 -
5 Years Quality of Life and Early Mobilization in ICU
|
||
Recruiting |
NCT05537298 -
Muscle Recovery After Critical Illness
|
||
Completed |
NCT05473546 -
Diarrhea and Stipsis in Critically Ill Patients (NUTRITI)
|
||
Not yet recruiting |
NCT05326633 -
Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors
|
Early Phase 1 | |
Not yet recruiting |
NCT06025760 -
Evaluation of Diaphragmatic Function and Quadriceps Muscle Thickness in Patients Receiving High Protein Nutrition
|
N/A | |
Completed |
NCT05048953 -
The Use of Musculoskeletal Ultrasound for the Detection of ICU-Acquired Weakness
|
||
Terminated |
NCT04095533 -
ICU Associated Weakness and Bedside Ultrasound Assessment
|
||
Terminated |
NCT04160039 -
Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit
|
N/A | |
Active, not recruiting |
NCT04944537 -
Current Situation and Analysis of ICU Management for Severe Trauma Patients in China
|
||
Recruiting |
NCT05865314 -
Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial)
|
N/A | |
Completed |
NCT04810273 -
Effect of Progressive Early Mobilization in Patients With TBI
|
N/A | |
Completed |
NCT04396197 -
Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care
|
||
Recruiting |
NCT04932330 -
Risk Factors of ICU-acquired Weakness
|
||
Completed |
NCT05008562 -
How COVID-19 Effects to Muscle Mass Change ın ICU?
|
||
Recruiting |
NCT05919940 -
Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )
|
N/A | |
Recruiting |
NCT05396066 -
Respiratory and Quadriceps Muscle Fatigability After an ICU Acquired Weakness
|
||
Recruiting |
NCT04998643 -
Muscle Catabolism and Outcomes in Children Following Cardiac Surgery
|
||
Not yet recruiting |
NCT06184945 -
Behavioral Economic & Staffing Strategies in the ICU
|
N/A | |
Completed |
NCT03550222 -
Muscle Evaluation Using Ultrasound in the Critically Ill
|